A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/1994
12/28/1994	EP0630374A1 Imidazole, triazole and tetrazole derivatives
12/28/1994	EP0630373A1 Indole derivatives as 5ht1c antagonists
12/28/1994	EP0630372A1 Heteroalkoxy benzazepines
12/28/1994	EP0630255A1 Mhc conjugates useful in ameliorating autoimmunity
12/28/1994	EP0630250A1 Pharmaceutical compositions containing monosialoganglioside gm 1? or a derivative thereof suitable for the treatment of parkinson's disease
12/28/1994	EP0630244A1 Muscarinic agonists
12/28/1994	EP0630239A1 Antipyretic and analgesic methods and compositions containing optically pure r(-) ketoprofen
12/28/1994	EP0557289B1 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents
12/28/1994	EP0540526B1 Quinuclidine derivatives
12/28/1994	CN1096780A Therapeutic agents
12/27/1994	US5376748 Antiepileptic agents, anticonvulsants
12/27/1994	US5376687 For treatment of central nervous system disorders
12/27/1994	US5376684 Aminobutyric acid antagonist; antiepileptic agent
12/27/1994	US5376672 Method for treating tension type headaches or headaches associated with drugs or their withdrawal
12/27/1994	US5376668 Cholinergic agents as cognition activators in treatment of Alzheimer*s disease
12/27/1994	US5376667 Derivatives of benzoylecgonine, ecgonine and their multiple pharmacological properties
12/27/1994	US5376661 Psychological disorders
12/27/1994	US5376382 Tablets, granulates and pellets with a high active substance content for highly concentrated, solid dosage forms of thioctic acid
12/22/1994	WO1994029449A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
12/22/1994	WO1994029336A1 New peptide derivatives
12/22/1994	WO1994029309A1 Spiro-substituted azacycles as neurokinin antagonists
12/22/1994	WO1994029303A1 Heterocyclic chemistry
12/22/1994	WO1994029299A1 Imidazole lipoxygenase inhibitors
12/22/1994	WO1994029298A1 8-amino-7-chloro-1,4-benzodioxan-5-carboxylic acid, -1-butyl-4-piperidinyl ester as a 5-ht4-receptor antagonist
12/22/1994	WO1994029295A1 Heterocyclic derivatives with immunomodulating activity
12/22/1994	WO1994029286A1 Analgesic dibenzoxazepines and dibenzothiazepines
12/22/1994	WO1994029275A1 Benz(b)azepine-2,5-diones useful in the treatment of neurodegenerative disorders
12/22/1994	WO1994029272A1 1-substituted isatin and oxindole derivatives as inhibitors of acetylcholinesterase
12/22/1994	WO1994029255A1 Aromatic acetylcholinesterase inhibitors
12/22/1994	WO1994028923A1 Multiple botulinum toxins for treating neuromuscular disorders and conditions
12/22/1994	WO1994028922A1 Treatment of neuromuscular disorders and conditions with different botulinum serotype
12/22/1994	WO1994028913A1 Methods and pharmaceutical compositions useful for treating neurological disorders
12/22/1994	WO1994028904A1 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
12/22/1994	WO1994028903A1 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
12/22/1994	WO1994028888A1 Use of isovaleramide as a mild anxiolytic and mild sedative agent
12/22/1994	WO1994025029A3 Use of sabeluzole in chronic neurodegenerative diseases
12/22/1994	DE4420856A1 Pharmaceutical composition with analgesic activity
12/22/1994	CA2165325A1 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
12/22/1994	CA2165324A1 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
12/22/1994	CA2165159A1 Analgesic dibenzoxazepines and dibenzothiazepines
12/22/1994	CA2164119A1 1-substituted isatin and oxindole derivatives as inhibitors of acetylcholinesterase
12/22/1994	CA2163995A1 Spiro-substituted azacycles as neurokinin antagonists
12/22/1994	CA2161811A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
12/22/1994	CA2161251A1 Benz(b)azepine-2,5-diones useful in the treatment of neurodegenerative disorders
12/21/1994	EP0629635A1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them
12/21/1994	EP0629402A1 Pharmaceutical compositions containing ipsapirone
12/21/1994	EP0629400A1 Idebenone compositions for treating Alzheimer's disease
12/21/1994	EP0629200A1 Epibatidine and derivatives, compositions and methods of treating pain
12/21/1994	EP0629199A1 Indole derivatives as 5-ht1 agonists
12/21/1994	EP0629190A1 Compounds as calcium channel antagonists
12/21/1994	CN1096515A New peptides
12/20/1994	US5374722 Bridged benzazepines
12/20/1994	US5374710 Compounds which release nitric oxide upon illumination
12/20/1994	US5374656 N-phenyl-n-alkoxycarbonylalkyl glycinamides, their preparation and the medicaments containing them
12/20/1994	US5374649 Indole derivatives and pharmaceutical use thereof
12/20/1994	US5374648 Nervous system disorders
12/20/1994	US5374643 Antiischemic agents
12/20/1994	US5374555 Protease catalyzed treatments of lignocellulose materials
12/20/1994	CA1333647C Heptapeptide analogs of somatostatin
12/19/1994	CA2125822A1 Therapeutic agent for alzheimer's disease
12/18/1994	CA2126158A1 19-nor steroids phenoxyalkylsulfonamide or phenoxyalkylsulfonylurea chain on 11 beta position, process and intermediates for their preparation, application as medicaments and pharmaceutical compositions containing them
12/16/1994	CA2125620A1 Ipsapirone medicament formulation
12/14/1994	EP0628556A1 Imidazopyridines
12/14/1994	EP0628548A1 Derivatives of 1,2,3,4-tetrahydro-9-acridinamine
12/14/1994	EP0628043A1 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist
12/14/1994	EP0628042A1 Serotoninergic ergoline derivatives
12/14/1994	EP0628041A1 Heterocyclic compounds and their preparation and use
12/14/1994	EP0628033A1 Benzodiazepin derivatives useful as cck-receptor antagonists
12/14/1994	EP0628030A1 2,3,4,5-TETRAHYDRO-1H --3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF $g(a)-SUBSTITUTED-ARYLACETAMIDES
12/14/1994	EP0627916A1 Pharmaceutical composition for use as a pain killer and containing (benzoyl-3 phenyl)-2 propionic-(r) acid
12/14/1994	EP0627915A1 Sprayable analgesic composition and method of use
12/14/1994	EP0573522B1 1-azabicyclo[3.2.2]nonan-3-amine derivatives
12/14/1994	EP0565558B1 Process and intermediates for preparing azabicyclo 2.2.2]octan-3-imines
12/14/1994	EP0498830B1 Glutamic and aspartic acid derivatives with antigastrin activity and a method for their preparation
12/14/1994	EP0324007B1 A pharmaceutical composition containing s(+) ibuprofen substantially free of its r(-) antipode
12/14/1994	CN1096197A Compositions containing esters of unsaturated fatty acids
12/14/1994	CN1096196A Injection solution for giving up addiction of drug addict and preparing method
12/13/1994	US5373023 Antiischaemic agent
12/13/1994	US5373022 Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
12/13/1994	US5373018 Antagonist to excitory amino acids on N-methyl aspartic acid receptor complex, theraputically effective in treatment of central nervous system disorder
12/13/1994	US5373003 1-azabicyclo[3.2.2]nonan-3-amine derivatives
12/13/1994	CA2067758C Piperidine and pyrrolidine derivatives
12/13/1994	CA1333485C Fused benzazepines
12/08/1994	WO1994028132A2 Opioid receptors: compositions and methods
12/08/1994	WO1994028031A1 New nimesulide salt cyclodextrin inclusion complexes
12/08/1994	WO1994028022A1 Novel protein having avidity with heparin-binding growth factor
12/08/1994	WO1994028016A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1)
12/08/1994	WO1994028003A1 Tricyclic defem sulphones as elastase inhibitors
12/08/1994	WO1994027998A1 Psoralen®* derivatives, their preparation and use
12/08/1994	WO1994027965A1 Novel 1-phenylalkanone 5-ht4 receptor ligands
12/08/1994	WO1994027964A1 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists
12/08/1994	WO1994027957A1 Compounds which release nitric oxide
12/08/1994	WO1994027625A1 Novel anxiolytic
12/08/1994	WO1994027614A1 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis
12/08/1994	WO1994027608A1 Methods and compositions for inducing sleep
12/08/1994	WO1994027605A1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use
12/08/1994	WO1994027603A1 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
12/08/1994	WO1994027599A1 Rectal compositions
12/08/1994	WO1994027591A1 Therapeutic substituted guanidines
12/08/1994	WO1994027589A2 Antidepressant dosage form

1 ... 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 ... 1833